IBHRE复习资料：起搏器相关知识.pptVIP

Above are Class I and IIa indications for CRT (Cardiac Resynchronization Therapy). Resynchronization therapy in the COMPANION trial directly compared pacing with (CRT-D) and without (CRT-P) defibrillation capability with optimal medical therapy. CRT-D reduced mortality by 36% compared with medical therapy. Modification of ventricular electromechanical delay with multisite ventricular pacing (“biventricular pacing and CRT”) can improve ventricular systolic function with reduced metabolic costs, ameliorate functional mitral regurgitation, and, in some patients, induce favorable remodeling wit